Follicular Helper T-Cell Lymphoma — Trials

Follicular Helper T-Cell Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

126 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 17
Recruiting: 10
Ph III recruiting: 2
Growth YoY: —
Industry share: 24%
Top sponsor: City of Hope Medical Center
Termination share: 27.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (24)

clinicaltrialsPublishedShowing 51–57 of 57 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00131937	Sorafenib Tosylate in Treating Patients With Recurrent Aggressive Non-Hodgkin's Lymphoma	completed	Phase 2	14	National Cancer Institute (NCI)NIH	1	Sep 3, 2015	clinicaltrials
NCT01198665	RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas(RADCHOP)	completed	Phase 1 / Phase 2	46	Samsung Medical CenterOTHER	1	Mar 3, 2015	clinicaltrials